Bristol Myers Squibb Co. Stock Rises Tuesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) inched 0.40% higher to $67.51 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.30% to 4,002.87 and the Dow Jones Industrial Average rising 0.98% to 32,560.60. This was the stock's second consecutive day of gains. Bristol Myers Squibb Co. closed $13.93 below its 52-week high ($81.44), which the company achieved on December 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) remained unchanged, Pfizer Inc. (PFE) fell 0.37% to $40.66, and Abbott Laboratories (ABT) rose 0.47% to $98.33. Trading volume (8.0 M) remained 469,263 below its 50-day average volume of 8.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 21, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 21, 2023 16:41 ET (20:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.